Feeling Crisp'r about Gene-Editing

CRISPR research got much traction in 2020 when it began to be seen as a possible medical technology. CRISPR-Cas9 is used to edit genes and alter parts of DNA. Investors listened when companies started showing success with these trials because rare genetic disorders could be eliminated, and quality of life increased by using this technique. Is there an opportunity for us to ride the trend?

Read More

Teledoc will see you now

As the pandemic pulls forward all digital platforms showing practical solutions for the online generation, Teledoc Health Inc. is uniquely positioned to lead in this space. Year-to-date Teledoc stock surged 133% but have you missed the opportunity to ride the trend? Will it be done after the pandemic? Let’s review a quick rundown for the case for Teledoc.

Read More
/page
Total Records: 2 - Page: 1 of 1